Literature DB >> 4117288

Histamine release in the dog after leukocyte lysate injection.

M T Kelly, R E Brashear, R R Martin, A White.   

Abstract

Mixed leukocyte suspensions, containing 10(6) leukocytes per ml, were prepared from dog peripheral blood by dextran sedimentation. Lysates of these suspensions, prepared by sonification, were administered intravenously to the autologous dogs. The plasma histamine levels were increased to an average value 320% above the control values (P < 0.001). The individual elements in the mixed leukocyte suspensions were separated by sucrose gradient and glass bead column fractionation procedures, and purified suspensions of platelets (no other formed elements present), lymphocytes (95 to 100%), and granulocytes (90 to 98%) were obtained. Lysates of these suspensions all had significant histamine-releasing activity when administered intravenously to dogs. Although leukocytes and platelets from other species are known to harbor mediators of histamine release, this study provides the first demonstration of the histamine-releasing activity of dog leukocytes and platelets. Many of the studies of leukocyte and platelet histamine-releasing factors have employed in vitro systems leaving the in vivo role of these factors in doubt. The present studies provide evidence that leukocyte and platelet histamine-releasing factors have in vivo activity.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4117288      PMCID: PMC416292          DOI: 10.1128/iai.4.3.228-231.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  9 in total

1.  SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS.

Authors:  Y RABINOWITZ
Journal:  Blood       Date:  1964-06       Impact factor: 22.113

2.  Release of histamine from mast cells by tissue extracts.

Authors:  G T ARCHER
Journal:  Nature       Date:  1958-09-13       Impact factor: 49.962

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

Review 4.  Effect of drugs on mast cells.

Authors:  A Goth
Journal:  Adv Pharmacol       Date:  1967

5.  Increased vascular permeability produced by human platelet granule cationic extract.

Authors:  R L Nachman; B Weksler; B Ferris
Journal:  J Clin Invest       Date:  1970-02       Impact factor: 14.808

6.  Mediators of histamine release from human platelets, lymphocytes, and granulocytes.

Authors:  M T Kelly; R R Martin; A White
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

7.  Plasma histamine levels and cardiovascular effects after compound 48-80.

Authors:  R E Brashear; J C Ross; R R Martin
Journal:  J Appl Physiol       Date:  1969-08       Impact factor: 3.531

8.  Isolation and characterization of permeability factors from rabbit neutrophils.

Authors:  N S Ranadive; C G Cochrane
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

9.  STUDIES ON THE MECHANISMS OF HYPERSENSITIVITY PHENOMENA. IX. HISTAMINE RELEASE FROM HUMAN LEUKOCYTES BY RAGWEED POLLEN ANTIGEN.

Authors:  L M LICHTENSTEIN; A G OSLER
Journal:  J Exp Med       Date:  1964-10-01       Impact factor: 14.307

  9 in total
  4 in total

1.  An inhibitor of histamine release from human leukocytes.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1974-05       Impact factor: 14.808

2.  Histamine release induced by himan leukocyte lysates: implication of a specific, complement-independent, noncytotoxic reaction.

Authors:  M T Kelly; A White
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

3.  Histamine release induced by human leukocyte lysates. Reabsorption of previously released histamine after exposure to cyclic amp-active agents.

Authors:  M T Kelly; A White
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

4.  Histamine release induced by human leukocyte lysates: effect of metabolic inhibitors and carbohydrates.

Authors:  M T Kelly; A White
Journal:  Infect Immun       Date:  1973-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.